Lessons From the Other Side of Academic Publishing: My Experience as an ASCO Journals Editorial Fellow
By Mona Hassan, MDFor many oncology fellows, including me, the ultimate goal is to have an academic career combining research and clinical practice. At the beginning of fellowship, and as your early career takes off, you focus on doing as much research as you can and publishing as many papers as possible. Of course,...
Leadership Is Action: My Experience in ASCO’s First Asia Pacific Leadership Development Program Class
"Leadership is not a single quality. Leadership consists of a series of actions you take, such as respecting others, taking responsibility, communicating to share values and goals, motivating and inspiring others," said Dr....
Yes! Tumor Boards Have a Place at All Major Oncology Meetings
Multidisciplinary tumor boards have become an essential component for the care of patients with cancer. Many countries require all hospitals that take care of patients with cancer hold tumor board meetings. A large number of countries even require tumor board decisions in order to have surgeries or medications approved. Comprehensive cancer centers, standalone cancer...
I Travel for Global Oncology: The Tale of My Great Journey at the University of Lahore in Pakistan
By Khalid El Bairi, MDOn a beautiful morning in early October 2022, I received a WhatsApp message from an enthusiastic young professor of pharmacy, Dr. Faisal Gulzar, who invited me to deliver presentations in a country very far from my home in Morocco—Pakistan! A country that I've never visited and that I mostly know...
Genomic Features Linked to Worse Outcomes in Young BC Patients
An analysis of the tumor biology of women with HR-positive, HER2-negative early breast cancer uncovered specific genomic alterations enriched in younger women. Medscape Medical News
Breast Cancer Surgery Timing Matters, but Is Faster Always Better?
Most women undergo primary breast cancer surgery within 8 weeks of diagnosis. Later may be associated with worse survival but some argue earlier surgery is not always better. Medscape Medical News
FDA Expands Abemaciclib Use in High-Risk Early Breast Cancer
Certain patients with high-risk early breast cancer can now receive abemaciclib (Verzenio) without needing Ki-67 testing. Medscape Medical News
HER2-Low Breast Cancer Is NOT a Separate Clinical Entity: Study
A large-scale analysis has revealed few biological and prognostic differences between HER2-low and HER2-negative breast cancer, and they should not be treated differently, say clinicians. Medscape Medical News
Who's at Higher Risk for Breast Cancer Recurrence?
A new study found that patients with ER-negative disease face a higher risk of a second breast cancer compared with patients with ER-positive disease. Medscape Medical News
Neoadjuvant Chemotherapy Underused in Breast Cancer
If the initial consult is with a surgeon, women are more likely to have up-front surgery for breast cancer. The study was published as a preprint and has not yet been peer reviewed. First Look
